Healthcare Industry News:  IGRT 

Devices Oncology

 News Release - May 31, 2007

Edward Cancer Center Treats Lung Cancer With Novel Adaptive Image-Guided Radiotherapy Using Trilogy(R) Technology from Varian Medical Systems

Doctor using images to modify the treatment as the tumor shrinks, sparing more healthy tissues

NAPERVILLE, Ill., May 31 (HSMN NewsFeed) -- Clinicians at Edward Hospital here are using Trilogy® technology from Varian Medical Systems (NYSE: VAR ) to offer some cancer patients a novel treatment that adapts to changes in the tumor so that more healthy tissue can be preserved. This is particularly promising in the treatment of lung cancer, when breathing is already compromised and the doctor must spare as much healthy lung tissue as possible.

In one case, doctors discovered a very large, fast growing tumor in a 69-year-old former smoker who had developed a persistent cough and wheezing. Tests revealed that she had small cell lung cancer, an aggressive form of the disease.

"We needed to use radiation right away to shrink the tumor quickly, because it was collapsing her lung and making it difficult for her to breathe," said Vasudha Lingareddy, MD, medical director of the Edward Cancer Center Department of Radiation Oncology.

Varian's Trilogy technology, equipped with an On-Board Imager® device for generating 3-D CT images on the spot, made it possible to pinpoint the tumor each day, fine-tune patient positioning prior to treatment, and see whether the tumor had shrunk enough to reduce the beam size and protect more of the healthy lung tissue. Lingareddy used these images to assess her patient's progress over time and to create new treatment plans that changed as the tumor grew smaller.

"The size of this tumor made it impossible to create a single treatment plan that could avoid harming too much of the surrounding healthy lung tissue," Lingareddy said. "So, our strategy was to replan as the tumor responded to treatment. After a couple of weeks, 3-D images revealed that the tumor had shrunk sufficiently for us to reduce the area being treated by about half. Our patient was elated."

Two weeks later, the clinical team created another treatment plan to better protect the patient's spinal cord, which was approaching the maximum dose that it can tolerate without injury.

"At that point, we generated new 3-D images and used them to create a new plan using beams that completely avoided the spinal cord," Lingareddy said. "This is a big change from how we used to do things, when we'd work out a treatment plan once at the beginning of treatment and then stick with it all the way through a course of treatment. Now, the treatment changes right along with any changes in patient anatomy that we can observe, thanks to image-guidance technology."

The World Health Organization reports that there were over 1.2 million new cases of lung cancer worldwide in 2000, and that the global incidence of lung cancer is increasing at 0.5% per year. A quarter of all cancer deaths in North America are from lung cancer, and 80-90% of these are the result of cigarette smoking.

In addition to lung cancer, Lingareddy and her team are using image-guided radiotherapy protocols to treat cancer of the prostate, breast, liver, pancreas, and head and neck.

According to Lingareddy, the steps involved in adapting a radiotherapy plan based on images were greatly facilitated by the tight integration of the elements that make up the Trilogy treatment system she uses at Edward Cancer Center. "There are other pieces of equipment that would allow you to do daily imaging, but this system makes it easy to use those images efficiently. Simulation is tightly integrated with treatment planning, imaging, and treatment delivery. Once we acquire the 3-D image, we can quickly and easily visualize the tumor response and use that information to modify the treatment plan. It's very efficient for the patient as well as for us, and very accurate."

ABOUT EDWARD CANCER CENTER

The Edward Cancer Center, located in Naperville, Illinois, combines state-of-the-art treatment and technology, research and unique support services and is one of the leading cancer programs in the Chicago area. The 40,000 square foot facility houses outpatient services for cancer treatment, including 36 medical oncology treatment stations; group, semi-private and private infusion therapy areas; IGRT, image-guided radiotherapy, the most advanced and precise radiation therapy available and PET/CT to assist physicians in identifying cancer, determining size and location of tumors and planning treatment. The Edward Cancer Center is located on the campus of Edward Hospital, a full service, regional healthcare provider serving residents of the western and southwest suburbs of Chicago. Edward is the largest employer in Naperville with 4,800 employees, including more than 800 physicians and 1,450 nurses.

ABOUT VARIAN MEDICAL SYSTEMS

Varian Medical Systems, Inc., of Palo Alto, California is the world's leading manufacturer of integrated cancer therapy systems, which are treating thousands of patients per day. The company is also a premier supplier of X-ray tubes and flat-panel digital subsystems for imaging in medical, scientific, and industrial applications. Varian Medical Systems employs approximately 3,600 people who are located at manufacturing sites in North America and Europe and in its 56 sales and support offices around the world. Additional information is available on the company's web site at http://www.varian.com/.

FORWARD LOOKING STATEMENTS

Statements in this press release regarding future business, events, plans, objectives, expectations, estimates, and other similar matters, including, but not limited to, statements using the terms "are giving," "is enabling," "can offer," "makes it possible to," and "have the potential to" constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements contained in this press release are subject to risks and uncertainties that could cause actual results to differ materially from those anticipated, including, but not limited to, the risks described in the company's Annual Report on Form 10-K and other reports filed from time to time by the Company with the Securities and Exchange Commission. These forward-looking statements represent the Company's judgment as of the date of this press release. The Company assumes no obligation to update or revise these forward-looking statements because of new information, future events, or otherwise.


Source: Varian Medical Systems

Issuer of this News Release is solely responsible for its content.
Please address inquiries directly to the issuing company.



FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.